Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Sulzbach

9 clinical trials in Sulzbach, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Sulzbach at a glance
9
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

9 trials in Sulzbach

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cemdisiran
  • Sponsor:Regeneron Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ranibizumab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:King's College Hospital NHS Foundation Trust
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ADX-038
  • Sponsor:Adarx Pharmaceuticals Inc.

Macular oedema

Not yet recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Humanised Igg2 Monoclonal Antibody Against Interleukin-6
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Faricimab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:GermanyGermany
  • Participants:65+ years
  • Substances:Ranibizumab
  • Sponsor:F. Hoffmann-La Roche AG
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tenecteplase
  • Sponsor:Universitaetsklinikum Tuebingen AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Bayer AG

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Sulzbach

What the registry says about research in the country

01 Age-Related Macular Degeneration Research

Comprehensive studies focusing on various forms of Age-Related Macular Degeneration (AMD), including both wet and geographic atrophy. Research aims to evaluate innovative treatment approaches and delivery systems.

  • Geographic Atrophy Treatment Evaluation
  • Neovascular AMD Management
  • Port Delivery System Assessment

Multiple trials exploring long-term safety and efficacy of novel therapeutic approaches for AMD patients.

02 Retinal Vascular Conditions

Investigating treatment options for acute Central Retinal Artery Occlusion (CRAO), focusing on early reperfusion therapy to preserve vision and improve outcomes.

  • Vision Recovery Assessment
  • Reperfusion Therapy Evaluation
  • Visual Acuity Improvement Studies

Research emphasizes time-critical interventions for better visual outcomes.

03 Uveitic Conditions

Clinical research examining new treatments for Uveitic Macular Edema, evaluating novel intravitreal therapeutics for improved patient outcomes.

  • Macular Edema Management
  • Intravitreal Drug Delivery
  • Functional Outcome Assessment

Trials focus on developing effective treatments for this challenging inflammatory condition.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.